Imugene Ltd
IMU
Company Profile
Business description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.
Contact
4-6 Bligh Street
Suite 12.01, Level 12
Sydney NSW 2000
AUSSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
5
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 7,849.40 | 17.50 | 0.22% |
CAC 40 | 7,984.93 | 80.22 | -0.99% |
DAX 40 | 17,932.17 | 186.15 | -1.03% |
Dow JONES (US) | 37,903.29 | 87.37 | 0.23% |
FTSE 100 | 8,121.24 | 22.89 | -0.28% |
HKSE | 18,178.82 | 415.79 | 2.34% |
NASDAQ | 15,605.48 | 52.34 | -0.33% |
Nikkei 225 | 38,236.07 | 37.98 | -0.10% |
NZX 50 Index | 11,874.04 | 6.46 | 0.05% |
S&P 500 | 5,018.39 | 17.30 | -0.34% |
S&P/ASX 200 | 7,587.00 | 17.10 | 0.23% |
SSE Composite Index | 3,104.82 | 8.22 | -0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Tietto Minerals Ltd TIE | 0.68 | 0.01 | 0.74% |
Telstra Group Ltd TLS | 3.59 | 0.05 | -1.37% |
BrainChip Holdings Ltd BRN | 0.25 | 0.04 | -12.28% |
Mesoblast Ltd MSB | 1.07 | 0.03 | -2.73% |
Pantoro Ltd PNR | 0.09 | 0.00 | 1.19% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
Melbana Energy Ltd MAY | 0.05 | 0.01 | -9.09% |
The Star Entertainment Group Ltd SGR | 0.41 | 0.01 | 2.50% |
South32 Ltd S32 | 3.55 | 0.05 | 1.43% |
Pilbara Minerals Ltd PLS | 4.06 | 0.01 | -0.25% |